evenfolioETF Details
First Trust·Health·FBT · NYSE Arca
First Trust NYSE Arca Biotechnology Index Fund (FBT)
- Price
- $278.55
- —30 Oct 2026
- Assets
- $3B
- Total net assets
- Expense ratio
- 0.55%
- Category 1.00%
- Yield
- 0.00%
- Trailing distributions
- 1Y return
- 47.7%+18.9%
- Category 28.8%
- 3Y CAGR
- 28.4%+6.9%
- Category 21.5%
- 5Y CAGR
- 11.4%+7.3%
- Category 4.1%
Loading NAV history…
First Trust NYSE Arca Biotechnology Index Fund
Calendar-year returns
Fund only: no comparison series covers this fund's history.
Risk statistics
Five years of daily closes. Risk-free rate 4% a year.
- Standard deviation
- —
- Maximum drawdown
- —
- Sharpe ratio
- —
- Sortino ratio
- —
- Beta
- —
- Alpha
- —
- R²
- —
- Information ratio
- —
- Upside capture
- —
- Downside capture
- —
- Tracking error
- —
| Period | 1M | 3M | 6M | YTD | 1Y | 3YCAGR | 5YCAGR | 10YCAGR | LaunchCAGR |
|---|---|---|---|---|---|---|---|---|---|
| ETF | +2.3% | +13.7% | +35.5% | +34.9% | +47.7% | +28.4% | +11.4% | +12.5% | +14.0% |
| Health average | 3.6% | 9.9% | 23.0% | 20.4% | 28.8% | 21.5% | 4.1% | 10.8% | 11.6% |
| Difference | -1.3% | +3.8% | +12.5% | +14.5% | +18.9% | +6.9% | +7.3% | +1.7% | +2.4% |
Holdings
The 10 largest positions make up 39.9% of the fund.
Top holdings
| Ticker | Holding | Weight |
|---|---|---|
| NTRA | Natera Inc | 4.67% |
| HALO | Halozyme Therapeutics Inc | 4.42% |
| ILMN | Illumina Inc | 4.39% |
| RGEN | Repligen Corp | 4.07% |
| NEO | NeoGenomics Inc | 3.97% |
| CORT | Corcept Therapeutics Inc | 3.83% |
| GMAB | Genmab AS ADR | 3.75% |
| ONC | BeOne Medicines Ltd ADR | 3.74% |
| AMGN | Amgen Inc | 3.54% |
| GILD | Gilead Sciences Inc | 3.50% |
Portfolio valuation
Weighted averages of what the fund holds.
- P/E
- 29.6
- P/B
- 4.4
- P/S
- 5.5
- P/CF
- 22.3
Sector allocation
Share of the equity the fund holds.
- Health care100.0%
Asset mix
- Stocks99.9%
- Cash0.1%
ETF details
- Issuer
- First Trust
- Category
- Equity · Health
- Ticker
- FBT
- Exchange
- NYSE Arca
- Inception
- 19 Jun 2006 (20.4 years)
- Structure
- Exchange Traded Fund
- Expense ratio
- 0.55% (category 1.00%)
- Holdings turnover
- 37% (category 51%)
- Distribution yield
- 0.00%
- Beta, 3 years
- 0.75
- Total net assets
- $3B
Prices and returns as of 30 Oct 2026; total return with distributions reinvested, before brokerage and taxes. Not investment advice.
Other health ETFs
Other ETFs in the Health category.
- ARKG · ARK Genomic Revolution ETFARK ETF Trust · $2.2B · ER 0.75%5Y -7.2%
- IHE · iShares U.S. Pharmaceuticals ETFiShares · $1.6B · ER 0.37%5Y 13.3%
- IHF · iShares U.S. Healthcare Providers ETFiShares · $1.4B · ER 0.37%5Y 2.5%
- FXH · First Trust Health Care AlphaDEX FundFirst Trust · $1.1B · ER 0.61%5Y 3.0%
- FTXH · First Trust Nasdaq Pharmaceuticals ETFFirst Trust · $1.1B · ER 0.60%5Y 12.6%
- PBPH · Portfolio Building Block World Pharma and Biotech Index ETFPortfolio Building Block ETFs · $1B · ER 0.13%